Aquafil S.p.A. (ECNL) Earnings Call Transcript & Summary

Good afternoon and thank you for joining our Main Goals and Financial Targets for the period 2023 and 2025. Let me -- the first thing that I want to do to introduce our new Chair, Ms. Chiara Mio. And I would like to give have the opportunity to say in a couple of words.

Thank you, Giulio. Good afternoon to everyone. Thank you for being here. I am the Chair of Aquafil since last assembly, during the last [ day of ] April. I am very honored to be the Chair of the Board of Directors for such an amazing outstanding company. I don't speak a lot because I have the piece of paper to be concise, so don't worry. Just we're welcome and to explain why we are here. As you know, Aquafil pays a lot of attention to the value creation through the whole supply chain and through the value chain. Aquafil is really an outstanding company dealing with sustainability. I'm very keen on sustainability, and it's really an honor to be chair of this company. Today, the aim of the day is to share with the financial community, the view of Aquafil on its value creation pattern. Due also to the situation that worldwide, we are facing, the situation is challenging. We are navigating very turmoiled environment, but we believe that it's important to share with you the view of the company. Value creation is a very comprehensive approach. There are several capitals to be keen of, natural capital environment as well, human resources, social capital. Today, we will deal with financial capital. Of course, with an eye on natural capital as it's part of the business model of Aquafil and human resources capital. But today, we want to discuss to have a disengagement with a specific stakeholder that is the financial community. So these days, for you, it's not only the one we will have. We are very pleased that you accept our invitation. So thank you for being here. And again, I hand over to Giulio and then to Roberto. Thank you.

Thank you, Chiara. Chiara didn't say, but she is a professor at the University of Venice and expert and passionate about sustainability already since more than 20 years. So she can tell us a lot about this very important topic. So today, we will have some -- we will touch some points about the current trading and the expectation for the fourth quarter of 2023 as well as what Aquafil is forecasting for 2024 and 2025. Originally, we wanted to make this presentation last spring, but then unfortunately, when after a good first quarter, the second quarter started a crisis that was partially unexpected, we decided to postpone in order to wait for some kind of stabilization rather than giving numbers that would have not been resulted in the reality and in our, let's say, quarters during 2023. After the presentation, of course, there will be a possibility of asking questions, and I hope that you will, let's say, ask a lot of questions. So how is the fourth quarter going? It is, of course, about the 20th of November. So we have an idea of how the fourth quarter is developing. And overall, we are not unhappy. As I said, after a very difficult April, May and summer period starting from September, we are seeing a stabilization in the European market because the other 2 markets, the United States and Asia Pacific are continuing a good trend But in the European market, we have seen especially September and October, 2 months with, say, order entry and revenues at least for the caprolactam and for the polymer business, even higher than 2022. While when we speak about United States, luckily, the strike of the automotive sector didn't influence much our sales. I remember that last year, September and October we're 2 big numbers, 2 big months in terms of orders for a number of reasons that I don't have now the time to explain. But this year are continuing with a good demand. Asia Pacific is continuing the trend of growth and will conclude another excellent year with regard to revenues and also profitability. What can I say about 2023? Well, of course, we are not happy with the result of this financial year. And maybe I'm here to try to let you understand that, yes, the numbers are not looking great on the contrary are horrible, but on the other side, maybe are not as horrible as they look like because, of course, there are some exceptional event that will not repeat during the next, let's say, quarters in the next 2 years, that, of course, will change in a very important manner, the look of our numbers. The volumes, as a matter of fact, are giving, yes, a minus in terms of 2023 versus 2022, but not big minus, something like between minus 3% and minus 4%. Even though the product mix has changed. So we have sold more polymer and less fibers, which is, of course, not good in terms of marginality because the value added is indeed lower. There has been and still there is, during the fourth quarter, a very strong impact related to the high unit value of the inventory of 2022. Unfortunately, starting from the beginning of the year, but there was a big acceleration during the second quarter, touching at the lowest level during the month of August, our raw material prices went down in an unexpected way. So we were forecasting some kind of decrease after the record of 2022 as a consequence of the energy crisis and the logistical disruption in the market when prices really hit let's say, record that has never been seen that far, okay? But in 2023, the drop was a very big and very sudden so especially the month of April, May, June, July and until August, I mean, we have seen, but Roberto will give you more color after my introduction, something that we have never experienced. So what are we expecting? Well, you all have seen the numbers of the third quarter. So during the fourth quarter, we think that our EBITDA will stay between EUR 45 million and EUR 50 million. But let me introduce a concept, the adjusted EBITDA that without the strong impact on the inventory would have been between EUR 68 million to EUR 70 million, which, of course, is bad in comparison with last year with our, let's say, average performance, but not as bad as it looks like now. And the net financial position, it will remain stable with last year numbers. So this is what we are going to expect given the current trading of the fourth quarter. Now as always, when you try to let the system work, it doesn't work. That doesn't work. Okay. Now, okay. Key messages. So after seeing this big change in our scenario, what have we -- what are we doing? What was our reaction starting from spring. We have managed in the best possible manner, our cost. Clearly, this is easier in the Italian system because of the so-called [ Cassa Depositi e Prestiti ] that can suspend pretty efficiently the labor cost for a certain number of weeks. So when you have a downturn of your demand, you can, let's say, lay off people temporaneousy without having a big impact on your cost, okay? So this is something that is very, say, good in the Italian labor market. But this is not possible in other areas. Other areas, I mean, especially Slovenia and Croatia, where we have a high number of personnel. And that, of course, we're not suspended in terms of cost like we could make during the same period in Italy. During 2020, there was a different situation. because every government granted subsidies in order to keep the personnel at the level of before. So if you are making a benchmark or a comparison within -- between the numbers of 2023 with the number of 2020, you should consider that during 2020, Aquafil got more than EUR 10 million subsidies in order to keep the personnel stable, so not to send people at home as we are doing in this period when, of course, such subsidies are not available. And then, of course, in 2020, we didn't have the impact on raw material and on inventory that we are suffering during 2023. Reduction in personnel costs. I will try to give you some numbers, but Roberto again, will return on this subject. For the year-end, we will have reduced our personnel of about 150 person and another 50 are due to be reduced between the first semester, between the first quarter and the second quarter of 2024. So altogether, 200 people less. Please remember that the total employment numbers of Aquafil are seeing 2,800 people. So it's a big reduction, including a shutdown, a complete shutdown of our plant in U.K., in Scotland which was, let's say, there, in order to service the local market, but after the Brexit and after the stabilization of, let's say, the borders and I mean, now it is possible to ship materials from Europe to U.K. without waiting weeks for clearance of the trucks. It is possible, let's say, to close this plant and to keep the market as we are doing right now. So the plant is now almost completely stopped and the people will be out before the end of 2023. Rationalization of working capital. This is another point that we have made. Last year, of course, with the global disruption of the logistical system, everybody had to increase the stock level in order to keep the service level to the market at a good, let's say, level. So what, of course, we have done this year has been a very strong reduction of our materials on stock, quantity-wise. To give you an idea, the stock level in terms of quantities at the end of this year, it will be lower than the one of 2019. So we are really -- we have really hit very, very strongly this part. Quantity-wise, something like minus 20% of volumes on stock, which, of course, has also impacted our manufacturing cost because we have sold more than what we have produced. And clearly, we have, let's say, had variable costs that were hit by this reduction. Thanks to our high manufactured capital quality, it means we have made a lot of investments and our equipment is really up-to-date worldwide. And because of the low saturation level, we can afford a lower capital expenditures during 2023, 2024. 2023, we were still having the, let's say, the completion of the investment launched in the previous years. But now in 2024 and 2025, we will have significant lower CapEx in comparison with the last 3 to 4 years. What we are not reducing is our research and development continuous effort. So we will keep our R&D expenses around to a little higher than 2% of our total revenues. In this case of 2022. It means in terms of absolute terms, more than EUR 13 million that are still dedicated to keep improving and introducing a lot of new, let's say, solutions to the market. I will not discuss today about this, but I would be more than happy to give some, let's say, answers in case you are asking for some questions at the end of this debate. I'm now handing over to Roberto, who will go more in detail.

Okay. So thank you very much. As said, we would like to draw your attention on the 2 key messages that we have just given, which means volumes and stock impact. So in relation to volumes for the current fiscal year, as said, we are expecting a decrease in a range between 3% to 4%. This variance should be or can be divided by the various business lines in which we are present as follows: First of all, our BCF for carpet yarn business, which I remind you all, represents more than 70% of our volumes and revenues will be substantially stable with a very limited decline of 2% to 4%. On the other hand, the textile business for MDF will be seeing a decrease between 20% to 22%. This trend is no news for you and no news for everybody. We saw it from the first quarter of [ 2000 ] this year. And unfortunately, this trend is still continuing. The good news between the 2 yarn or fiber business is that our ECONYL branded products remain stable. Moving once again, the resilience of this brand or this fiber compared to the more regular or fossil-based one. Last but not least, our polymer business, which includes the Engineering Plastics business will be growing between 16% to 18%. This, of course, is the result of the completion during the 2022 of our industrial factory and industrial production and the rollover and the ramping up of the volumes that happened during and through the year. Another important item, which is I guess, of cumbersome paramount, you choose the way you want to describe it, importance is, of course, the stock impact. As said, by stock impact, with the difference between high or the unitary value at the end of 2022 of our inventories compared with the fiscal year '23 market value. In order to try to explain better what has happened, we would like to, let's say, draw or focus your attention on this raw material, which is caprolactam, that represented for us the main fossil-based raw material that we purchase. As you can see from the graph, historically, the variance and the price variance of this raw material has always been in a limited range. What we have seen, though, since the beginning of '21 until the third quarter, beginning of fourth quarter of '22 is a constant growth of the price of this raw material. A constant growth that led the price of this raw material to increase in 70% -- by 70% in 20 months. Then from the beginning of the fourth quarter 2022, we have seen a sharp decline and a drop of the prices, which have brought this raw material to lose 40% in less than 9 months. Because at the beginning of July, the price was indeed lower by this percentage. Maybe said like that is a little bit vague. But if you put this in numbers, it means that if you were purchasing 100,000 tonnes at the beginning of 2021, you would have had EUR 2, your cost would have been EUR 200 million. The same EUR 200 million would have become EUR 340 million at the end -- at the beginning of Q4 '22. To then go back to EUR 200 million at the beginning of Q3 '23. Such a fluctuation, you can understand that it's almost impossible to foresee and also to handle. Unfortunately, as you can see, the drop happened all during this fiscal year, basically, while the building up took almost 2 fiscal years. What are the updates? As of today, during this quarter, we have seen that it looks like that the spike and the irrational movement of this raw material, it's over or it seems to be over. So it's getting back to its usual trend and probably is linked with, as [ Mr. Morati ] said for postpandemic logistic crisis and so on and so forth. As a result, as you know, at the end of Q3, our EBITDA was EUR 37 million, which is significantly lower compared to last year, but this EUR 37 million are including and embedding EUR 20 million of stock impact. What we are expecting for the last quarter of the year is that this impact will continue yet with a minor importance compared to the previous quarter. Just to give you some rough number, on the second quarter of this fiscal year, the stocking impact was more than EUR 11 million. So it's queuing out it's finishing because on one side, the price of the material is getting more stable on the other one, as we said before, our quantity in inventories are getting lower. We decreased by 27% in terms of quantity, our inventories. So the end of the fiscal year 2023 will be presenting an EBITDA in a range between EUR 45 million to EUR 50 million. We believe that the real performance of the company should be looked excluding or, let's say, at least taking into consideration this stock impact, which is between EUR 23 million to EUR 25 million. Hence, bringing it back to an adjusted EBITDA or if you want a more operative EBITDA between EUR 68 million to EUR 70 million. Yet again, this slide is just to reinforce this message that during this fiscal year has been really exceptional in terms of impact from this inventory from the trend and the dynamic of the prices of the raw material. So when we will be presenting EUR 45 million to EUR 50 million EBITDA? You should actually read EUR 68 million to EUR 70 million because that's the performance that the company would have had if no fluctuation or not such a fluctuation of the caprolactam would have occurred. Now I leave the floor to our CEO for the view on '24, '25.

Thank you, Roberto. So what is the view for the future? Clearly, if we have given the same numbers at the beginning of this year, we would have given a more optimistic view. Of course, we were exiting from 2 years of good sales of revenues growing and let's say, also demonstrating our capability of passing through the raw material price increases that we have suffered during the first, let's say, the last 2 fiscal years, okay? And now we have given back to the market. So we have not given back margins. So we have not reduced more than the drop of the raw materials. We have reduced in the same range of the drop of the raw material with ECONYL, of course, enjoying a better situation. But I will speak about volumes, what is the scenario that we are expecting in terms of volumes during 2024 and 2025 and then we will comment together with Roberto EBITDA and net financial position. About volumes, we expect an overall volume increase in all product lines between 4% to 7% at the group level. Which means not yet a recovery for all the business lines of the levels of 2021 and 2022, with carpet yarn getting close this because of, let's say, a situation in Europe that seems to stabilize and also because a growth of market share, which is continuously happening in the market. Nylon textile filament still not recovering, if not marginally less than half the drop that we are suffering. So we believe that the inventory level of this industry is still high. And takes naturally longer than the one of the carpet business because the carpet business, the value chain is much shorter and people are not able to build up too much inventories. And so when it is the moment to act, they react quicker and the inventory decrease last shorter than the one of textile. The polymers I mean it's a business line that we count a lot, especially to keep our revenues in the European market, let's say, with some plus in front, given the fact that for sure, the fiber market in Europe, generally speaking, is not growing and our market share is still high. So it is, of course, more difficult to gain market shares other than some competitors exit from the market. So the reason why we have made this investment is because we believe that ECONYL can say a lot of things to the engineering plastic market. But secondly, also because this is an industry which is still growing, not maybe growing as it was growing some years ago, but still with some positive look for the next years. So speaking more, giving more colors about the geographical development, we think that in U.S.A., we will still enjoy a market growth with regard to the carpet yarn, the NTF, you all remember that we have a subsidiary in North Carolina that we took over during 2019 keeps recovering. In this case, we suffered the biggest loss of volumes during the second semester of 2021 and then a slow recovery, now stabilizing at around 90% between 85% to 90% of the original levels, but seeing some positive trend also because a big competitor in Mexico stopped to manufacture during the previous quarter. So we will see some effects in the American market shortly, okay? But U.S.A. for us is a good, let's say, place where to be. So we should keep having a very good results in terms of revenues and also in terms of profitability. In BCF, we are seeing some market growth. We are still gaining shares in the automotive market, gaining shares in the commercial market and, let's say, enjoying the favor of the clients. NTF, a partial recovery, while polymers, new -- there's a new perspectives that are reinforced especially by the engineering polymer Engineering Plastic business with the investment that we completed at the end of 2022 and that we, say, started up during 2023. The Asia Pacific market, which is represented by BCF by carpet yarn, plus some sales of textile filament that are going 100% ECONYL to Japan, Taiwan and Korea, the developed area keeps, let's say, a good outlook because, of course, it's an area where construction and let's say, growth despite the crisis, still, let's say, higher than the one that we are having here in Europe. '25 versus 24, it's similar. Carpet yarn, of course, still we believe that at, let's say, global level, we should post another growth. And this also because we are starting to develop some new products in areas where we were not present before. Nylon textile filament recovering, but still around 10% lower than the volumes of 2022. This is because certain products and certain markets have disappeared. Basically, with the high prices of raw materials, in 2022, especially in Europe, some customers switched to other materials, For example, Nylon 6 instead of Nylon 66. And when they switched commodities Nylon 6, they started to buy from China and not buying from local customers. Especially, for example, the Turkish market that were representing not a minor portion of our sales until 2021, presently is, of course, touched by the crisis in Turkey, touched by the export crisis because, of course, Turkey was exporting to Continental Europe as well as to the Russian say, states, which, of course, are not very strongly demanding during this period, but also touched by the importation of Nylon 6 coming from Mainland China, which is sold at very low prices, which for us makes no sense to compete. The polymer market, we are still confident that we will keep growing. Please remember that our engineering plastic capacity, we are speaking about 1% of the total market and that we are counting on what on, let's say, conventional recycled material. So our fiber, which is transformed into a recycled nylon for the engineering plastic industry. So in this case, it's not ECONYL, but mechanically recycled as well as we are investing a lot in developing new projects with our ECONYL, let's say, first grade materials, for example, for the sunglass industry, but not only. So again, also in '25, U.S.A. is, for us, a growing market. This is because there are some contracts with other vendors that are going to expire at the end of 2024 and that we have already, let's say, agreed that we will take over part of this contract during 2025. The textile filament business of our North Carolina subsidiary should have completed the recovery. So we are not betting on selling more than what we were selling before 2021. So we are betting on selling what we were selling in 2021. Europe BCF continues growth in terms of recovery from the past levels because please remember that if you go, let's say, some years ago, we were selling much more than what we are selling presently because after COVID, the European market has never recovered, not even closely the original sales. And yet still recovery but below the 2022 levels and polymers expansion, as I have just explained. Asia Pacific, still a growing market, still the area where we are running at full capacity, still where we are slightly short of capacity. So where we are still planning some minor investments to keep capacity, let's say, in line with the present demand. Good news about ECONYL we confirm the target of reaching around 60% of our fiber revenues for the end of 2025. We are to the lowest to the 50% so it means that we think we can grow of another 20% our sales in terms of revenues, not in terms of quantities during 2024 and 2025. We are continuously expanding our sales in Asia, continuously expanding our sales in the North American market and also targeting some new, let's say, markets here in Europe. Efficiencies, this is just to give you an idea. As I said, headcount reduction around 200 people before the middle of 2024. Of course, we have to post productivity increases through some automation projects and better utilization rate, which, of course, this year was also hit by the inventory reduction. A lot of projects about making our system and more energy efficient, also cost effectiveness initiatives like saving of raw materials, saving of energy saving and improving of productivity in every level, including logistics and transportation which is an important cost factor for Aquafil. Now I will leave the floor to Roberto, who will go into, let's say, more numbers, more numerical explanation.

Let's see if we can switch. Okay, thank you. So the information that you just received translated into numbers would be basically as follows. So volumes on one side, efficiencies on the other. The 2 together should provide or should bring approximately EUR 16 million to EUR 22 million additional EBITDA cumulative in the next 2 years. So in terms of volumes, as we said, the total benefit of the total increase in our EBITDA that you are expecting will be in the range between EUR 7 million to EUR 10 million cumulatively. Again, in a nutshell, BCF, stable growth, NTF market recovery polymer is the expansion of our presence in the market, where we are still very small. So there's plenty of room. On the other hand, efficiencies, as we said, we are targeting the decrease and the optimization of our headcount. At this moment in time, the target, as you heard, is to arrive to 200 people by mid of next year. At the end of October, we were 144 which means 5% of our headcount since the beginning of the year. Then production efficiency, production increase. As we said, during this year, of course, our production efficiency was not at the top level or was not at least our historical levels. So we are counting on recovering them. And then we have started various projects in terms of improving our cost structure in terms of, as I said, logistics, transportation, energy. These -- all these elements to and then, of course, we should not forget that we have already started part of our rationalization or production structure, at least in Europe, where with the closing of our U.K. factory. All these items together should bring in the next 2 years a saving or an improvement of our EBITDA between EUR 9 million to EUR 12 million. Please, when you see these numbers always keep in mind, the total magnitude of the cost that we are talking about. So we are talking about small percentages. So it seems to us reasonable to give us ourselves these targets. Starting then, so in order to explain you the evolution starting from our adjusted EBITDA of EUR 68 million to EUR 70 million, we should land in 2024 in a range between EUR 76 million to EUR 82 million. And then in '25, in a range between EUR 84 million to EUR 92 million. One important item of this presentation is, of course, we are starting from our adjusted EBITDA because our estimation is that in the next year, the no stock impact with the same magnitude of the one occurred during this year, should be happening again based on our best estimation of the market information that we have. Last but not least, one item that everyone is really paying attention on, of course, is our net financial position. As said, this year has been a year in which the focus of this company has been in controlling and containing our net financial position as much as possible. I think that the target of year-end between [250, 260 ], considering the open at [ 247 ], the distribution of dividends and so on and so forth is a good performance. And this effort is here to remain. It's here to remain in '24 and is here to remain in '25, meaning that we are giving us a target to ourselves a decrease of our financial position in a range between EUR 50 million to EUR 60 million in the next 2 years. How are we going to do that is pretty simple. So after the delivery of our estimate from EBITDA, we are going to invest CapEx in the range between EUR 25 million to EUR 30 million, which is a range lower compared to the CapEx that we spent in '20, '21 and '22 you can check the numbers. Of course, this CapEx will be used to continue to improve our efficiency, the maintenance and some strategic investments that will be able to -- will allow us to deliver additional profits in the next 2 years. Then of course, we will have to pay interest and tax, unfortunately, also tax. And at the end of 2024, we're expecting to arrive at EUR 200 million -- in a range between EUR 225 million to EUR 235 million. And at the end of 2025, in the range between EUR 190 million to EUR 200 million, which just to give you a rough idea, will mean that our, and net financial position on EBITDA ratio well in a range between around [ 3% ] at the end of next year and around [ 2.5 % ] at the end of 2025. So now I hand over to Mr. Bonazzi for the question.

Thank you. Talking about raw material prices, we expect that 2024 will be flat around the present levels, and there will be a sharp slight growth during 2025. The present situation of our supplier is very complicated. You have all seen all the profit warnings that has been launched by the chemical industry during the last couple of quarters. This is because, of course, the suffering low utilization and super low marginality. So this is something that cannot last forever. But nevertheless, we are speaking always about a possible increase, let's say, very marginal in comparison with the one that we have seen, let's say, starting from the second semester of 2021. The range that you are seeing, EUR 76 million to EUR 82 million is basically depending on the development of the volumes that we will be able to reach during the next couple of years. So if we are not able to grow anything, we will stay at EUR 76 million. If we are targeting, let's say, our -- the numbers I have just mentioned short ago, the EUR 82 million will be more than achievable. Nevertheless, of course, we will keep an eye and stay very focused in controlling our capital expenditures that eventually can be slightly further reduced without any compromise to our quality without any compromise to the quality of our assets nor to the possibilities of, let's say, delivering higher sales and better numbers to our clients. With that being said, I want to conclude this presentation, and I'm now ready. We are now ready, Roberto and myself, to answer to your questions, if there are. Gianluca, strange. You never ask for questions.

Thank you, Giulio. I have actually, I think, 3 questions. The first one, obviously, you will breach the covenants in 2023. And under your assumption, you will be well below the covenants by 2024. Can you give us some color how you are dealing with both the banks and the proper placement. So if we can expect a kind of temporary increase in the cost of debt or anything that you can disclose at this time will be very useful. Secondly, I do not see any cash out in the Slide 18 related to the rationalization at closing the plant in the U.K., the 200 layoff. That is because they are already included in '23 or we should expect something happening also in '24? And then last, but not but I think it's important. On the previous slide, 17, I just see efficiencies and volume. I do not see price and mix. Price can be a question mark, but mix because of the expected growth of ECONYL to 60%. And because now the polymers have lower marginality, but I do expect the Engineering lasting in due time to have a better return. Is this number on the conservative side because it's lacking these 2 components?

Thank you, Gianluca. I will leave Roberto answering to the question number 1 and question number 2, and I will answer right now to the question number 3. Yes, we have been, let's say, very prudent but also let's not forget that there is some inflation ongoing. So clearly, we have to consider that labor costs are growing. Maybe this is something that we are not noticing much here in Italy, at least for the time being. But it's a real, let's say, fact with regard to the rest of the world. So not only to United States, where labor prices have doubled during the last 3.5 years, okay? But here in Europe, outside of Italy, say, salaries are growing in line with inflation. So last year, 9%. This year similarly. And then, of course, they will start to go down when, of course, inflation process will reenter in the normal pace. In Italy, thanks to, let's say, [indiscernible] and thanks to a different situation. For the time being, at least, we are not discussing about salary increases in the range of 10%, but nevertheless, certain inflation we have to consider. So we have tried to keep this possible cost increases in, let's say, being matched by other, let's say, positive factors that we should enjoy during the coming 2 years. I will leave to Roberto also because together with Sergio and Gabriela, they are enjoying discussing with our lenders, the present situation.

So we are currently in process of in discussion with the various financial institutions. So the process has started already. It's ongoing. Some of the financial institutions were waiting the Q3 results. We're waiting this meeting in order to have a better visibility. And I guess that the discussion are going to go on and on until the end of the fiscal year. So far, we have no reason to be negative about it. In relation to costs, I think it's too early to say. So we want to first -- I prefer first to get to the end of the process and then make a quote and give you details if needed on how much the cost is going to be. For the time being, I prefer not to disclose anything about that.

Because there are some financial lenders here. So if we start saying, yes, we will pay more. For sure, you will pay more than more.

Just from my understanding, so we should expect the net debt target to go up because they may include the cash out, let's say, in the future or in the target that you are giving, you are already...

Right Slide #18, when you see interest, tax and others, EUR 24 million to EUR 29 million is significantly higher than the numbers of this year. Something is already prudentially included.